Stockscreener 앱 받기
1.67
13.61%
0.20
시간 외 거래:
1.62
-0.05
-2.99%
Codexis Inc 주식(CDXS)의 최신 뉴스
Codexis rises after Q4 beat, strong outlook - MSN
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Biocatalysis and Biocatalysts Market is expected to Hit US$ 6.7 - openPR.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue GuidanceHas The Bull Case Changed? - simplywall.st
Short Interest in Codexis, Inc. (NASDAQ:CDXS) Grows By 26.2% - MarketBeat
Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance - Yahoo Finance
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
Codexis Stock Plummets Amid Financial Struggles - StocksToTrade
Why did CDXS stock jump 7% today? - MSN
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - Sahm
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Sahm
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Sahm
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com UK
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal - Investing.com India
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance By Investing.com - Investing.com India
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Benzinga
Codexis Shines as Q4 Profit Sparks Investor Enthusiasm - StocksToTrade
Codexis Surpasses Q4 Expectations, Stock Price Volatility Anticipated - timothysykes.com
Codexis (CDXS) Q4 2025 Earnings Call Transcript - AOL.com
Codexis stock jumps on Q4 earnings beat, strong 2026 outlook - National Today
Codexis (CDXS) Surges on Strong Q4 2025 Results and Optimistic O - GuruFocus
Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript - Insider Monkey
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha
Codexis, Inc. 2025 Annual Report: Advancements in ECO Synthesis Platform and Pharma Biocatalysis for Therapeutics Manufacturing - Minichart
Codexis: Q4 Earnings Snapshot - theheraldreview.com
Codexis (CDXS) Expects Current Funds to Last Through 2027 - GuruFocus
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Sur - GuruFocus
Codexis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Codexis Surpasses Q4 2025 Expectations with Strong Revenue Growth - Investing.com Nigeria
Codexis (CDXS) Surpasses Q4 Expectations for Earnings and Revenue - Bitget
CDXS: Strong 2025 revenue and ECO Synthesis progress set the stage for continued growth in 2026 - TradingView
Codexis Q4 Earnings Call Highlights - MarketBeat
1.20%
0.06%
자본화:
|
볼륨(24시간):